Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CREST-E
NCT00712426Phase 3Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2009
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of creatine in Huntington's disease (HD), sponsored by Massachusetts General Hospital. Started Sep 2009; status: terminated.
02
Drugs
creatine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT00712426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712426.